Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725772 · ClinicalTrials.gov registry record
Comparison of Health Care Delivery Methods in Parkinson's Disease
A clinical trial, sponsored by University of Arkansas.
- Completed
- Registry status
- 30
- Enrollment target
NCT05725772: Completed study, sponsored by University of Arkansas.
NCT05725772 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05725772 has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The goal of this observational study is to compare the ability to perform telemedicine visits at home, at a regional clinic close to home, and in-person in People with Parkinson's disease. The main question it aims to answer is whether telemedicine assessments provide high quality care to people with Parkinson's disease. Participants will perform a regular clinic visit followed by research evaluations of their disease. Researchers will compare the results of these assessments at the different visit types to see if there are differences in the results.
Primary Outcome
Feasibility of remotely collecting high-quality research data on a smartphone, tablet, or home computer.
Interventions
- OTHER Location of Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2023-12-30 |
What the finished NCT05725772 record still lists
NCT05725772 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Location of Visit is the first listed.
NCT05725772 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05725772 about?
NCT05725772 is a clinical study titled "Comparison of Health Care Delivery Methods in Parkinson's Disease". The goal of this observational study is to compare the ability to perform telemedicine visits at home, at a regional clinic close to home, and in-person in People with Parkinson's disease. The main question it aims to answer is whether telemedicine assessments provide high quality care to people wit...
What is the current status of trial NCT05725772?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2022-12-13. Estimated completion is 2023-12-30.
What interventions are being tested in trial NCT05725772?
The interventions under investigation include: Location of Visit (OTHER).
Who is sponsoring clinical trial NCT05725772?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI